---
$id: https://graph.org.ai/products/commodity/51281608
$type: Product
source: UNSPSC
code: "51281608"
title: "Butikacin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butikacin

**UNSPSC Code**: 51281608
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C22H45N5O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I61243PDCC, chemically known as uk-18,892 but generally known as butikacin, which bears US NIH Compound Identifier 65487. European Medicines Agency schedules Butikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06017MIG. The term BUTIKACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). BUTIKACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butikacin under HS 29419000 and SITC 54139. As of Q4 2014, BUTIKACIN remains the US FDA Preferred Term for this commodity. Butikacin bears US NLM identifiers UMLS ID C0054256 and NCI Concept Code C90637. SMILES: O(C1C(NCC(O)CCN)CC(N)C(OC2OC(C(O)C(O)C2O)CN)C1O)C1OC(C(O)C(N)C1O)CO.

